Tulobuterol, aβ2-agonist, Attenuates Eosinophil Adhesion to Endothelial Cells

Tulobuterol can decrease adhesion of blood eosinophils to endothelial cells. This finding suggests that tulobuterol patches have anti-inflammatory properties, and may therefore contribute to the treatment of airway inflammation in asthma.